
3D Bio Corp - Product Pipeline Analysis, 2022 Update
Description
Summary
3D Bio Corp (3D Bio) is a biologics and bioprinting company. The company operates as a biotechnology company that specializes in regenerative medicine and devices. The company's pipeline products includes AuriNovo, AnnuNovo, DiscNovo and NasaNovo. The company provides bio printing platform which focuses on whole tissue living implants for near term indications. It has lab and factory facilities in Ithaca, New York and engineering workshop in Brooklyn, New York. The company was funded by Kairos Ventures. 3D Bio is headquartered in New York, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
3D Bio Corp (3D Bio) is a biologics and bioprinting company. The company operates as a biotechnology company that specializes in regenerative medicine and devices. The company's pipeline products includes AuriNovo, AnnuNovo, DiscNovo and NasaNovo. The company provides bio printing platform which focuses on whole tissue living implants for near term indications. It has lab and factory facilities in Ithaca, New York and engineering workshop in Brooklyn, New York. The company was funded by Kairos Ventures. 3D Bio is headquartered in New York, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company 3D Bio Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
31 Pages
- 3D Bio Corp Company Overview
- 3D Bio Corp Company Snapshot
- 3D Bio Corp Pipeline Products and Ongoing Clinical Trials Overview
- 3D Bio Corp – Pipeline Analysis Overview
- 3D Bio Corp - Key Facts
- 3D Bio Corp - Major Products and Services
- 3D Bio Corp Pipeline Products by Development Stage
- 3D Bio Corp Ongoing Clinical Trials by Trial Status
- 3D Bio Corp Pipeline Products Overview
- 3D Printed Breast Implant - Lupectomy Reconstruction
- 3D Printed Breast Implant - Lupectomy Reconstruction Product Overview
- 3D Printed Implant - Damaged Meniscus
- 3D Printed Implant - Damaged Meniscus Product Overview
- 3D Printed Implant - Kidney Failure
- 3D Printed Implant - Kidney Failure Product Overview
- 3D Printed Implant - Liver Failure
- 3D Printed Implant - Liver Failure Product Overview
- 3D Printed Implant - Rotator Cuff Tear
- 3D Printed Implant - Rotator Cuff Tear Product Overview
- 3D Printed Implant - Severed Nerves
- 3D Printed Implant - Severed Nerves Product Overview
- AnnuNovo
- AnnuNovo Product Overview
- AuriNovo
- AuriNovo Product Overview
- AuriNovo Clinical Trial
- DiscNovo
- DiscNovo Product Overview
- NasaNovo
- NasaNovo Product Overview
- 3D Bio Corp - Key Competitors
- 3D Bio Corp - Key Employees
- 3D Bio Corp - Locations And Subsidiaries
- Head Office
- Recent Developments
- 3D Bio Corp, Recent Developments
- Dec 06, 2019: 3DBio Therapeutics receives FDA rare pediatric disease designation for auriNovo for ear reconstruction in microtia patients
- Nov 19, 2019: 3DBio Therapeutics receives Orphan Drug Designation for AuriNovo for Ear Reconstruction in Microtia Patients
- Apr 02, 2019: 3DBio Therapeutics announces appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to board of directors
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: D Bio Corp Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: D Bio Corp Pipeline Products by Equipment Type
- Table 3: D Bio Corp Pipeline Products by Indication
- Table 4: D Bio Corp, Key Facts
- Table 5: D Bio Corp, Major Products and Services
- Table 6: D Bio Corp Number of Pipeline Products by Development Stage
- Table 7: D Bio Corp Pipeline Products Summary by Development Stage
- Table 8: D Bio Corp Ongoing Clinical Trials by Trial Status
- Table 9: D Bio Corp Ongoing Clinical Trials Summary
- Table 10: D Printed Breast Implant - Lupectomy Reconstruction - Product Status
- Table 11: D Printed Breast Implant - Lupectomy Reconstruction - Product Description
- Table 12: D Printed Implant - Damaged Meniscus - Product Status
- Table 13: D Printed Implant - Damaged Meniscus - Product Description
- Table 14: D Printed Implant - Kidney Failure - Product Status
- Table 15: D Printed Implant - Kidney Failure - Product Description
- Table 16: D Printed Implant - Liver Failure - Product Status
- Table 17: D Printed Implant - Liver Failure - Product Description
- Table 18: D Printed Implant - Rotator Cuff Tear - Product Status
- Table 19: D Printed Implant - Rotator Cuff Tear - Product Description
- Table 20: D Printed Implant - Severed Nerves - Product Status
- Table 21: D Printed Implant - Severed Nerves - Product Description
- Table 22: AnnuNovo - Product Status
- Table 23: AnnuNovo - Product Description
- Table 24: AuriNovo - Product Status
- Table 25: AuriNovo - Product Description
- Table 26: AuriNovo - A Multicenter, Single Arm, Prospective, Open-Label, Staged Study of the Safety and Efficacy of the AuriNovo Construct for Auricular Reconstruction in Subjects With Unilateral Microtia
- Table 27: DiscNovo - Product Status
- Table 28: DiscNovo - Product Description
- Table 29: NasaNovo - Product Status
- Table 30: NasaNovo - Product Description
- Table 31: D Bio Corp, Key Employees
- Table 32: Glossary
- List of Figures
- Figure 1: D Bio Corp Pipeline Products by Equipment Type
- Figure 2: D Bio Corp Pipeline Products by Development Stage
- Figure 3: D Bio Corp Ongoing Clinical Trials by Trial Status
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.